- Home
- BJDX vs CRIS Comparison
BJDX vs CRIS Comparison
Compare BJDX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BJDX | CRIS |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 865.6K | 976.1K |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BJDX | CRIS |
|---|---|---|
| Price | $2.15 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 155.8K | ★ 582.9K |
| Earning Date | 11-17-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 86.65 | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | $249,040.00 | ★ $9,898,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.46 | $0.33 |
| 52 Week High | $30.52 | $2,981.00 |
Technical Indicators
Market Signals| Indicator | BJDX | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 85.62 | 29.19 |
| Support Level | $0.80 | $0.33 |
| Resistance Level | $4.19 | $5.50 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | 0.10 | 0.45 |
| Stochastic Oscillator | 85.07 | 97.66 |
Price Performance
Historical ComparisonAbout BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.